2012 - TTS International Congress

Immunosuppression in Liver Transplantation

47.7 - Two Years Follow Up after Conversion 1:1 from Twice to Once-Daily Tacrolimus in Liver Transplantation: Quality of Life, Patients´ Compliance and Drug Efficacy Evaluation

Presenter: Luca, Toti, ,
Authors: Luca Toti

You must be logged in to view recordings

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.